Quick Answer
Harmony Biosciences Holdings, Inc. reported Gross Profit of $670.11 million for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $670.11M | +20.1% |
| 2024 | $557.92M | +21.1% |
| 2023 | $460.79M | +30.0% |
| 2022 | $354.37M | +41.8% |
| 2021 | $249.92M | +89.3% |
| 2020 | $132.00M | +2887.9% |
| 2019 | $4.42M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $179.81M | +25.5% | +10.8% |
| June 30, 2025 | $162.34M | +15.4% | +6.3% |
| March 31, 2025 | $152.74M | +20.1% | +6.6% |
| September 30, 2024 | $143.26M | +11.9% | +1.8% |
| June 30, 2024 | $140.67M | +28.8% | +10.6% |
| March 31, 2024 | $127.13M | +29.3% | -0.7% |
| September 30, 2023 | $127.97M | +35.8% | +17.2% |
| June 30, 2023 | $109.21M | +23.9% | +11.0% |
- Harmony Biosciences Holdings, Inc. showed an increase of +20.1% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, Harmony Biosciences Holdings, Inc.’s gross profit has grown by 15067.7% (from $4.42 million to $670.11 million).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: